CSIRO says it welcomes public discussion about the ethics of Artificial Intelligence (AI) following the release of 'Artificial Intelligence: Australia’s Ethics Framework'.
The discussion paper, developed by CSIRO’s Data61, is designed to encourage a conversation on how Australia will develop and uses AI.
"It identifies key governance principles and measures that can be used to achieve the best possible results from AI, while keeping the well-being of Australians as the top priority," said CSIRO in a statement.
According to CSIRO chief executive, Dr Larry Marshall, as AI is increasingly used in homes, workplaces and communities, Australia must ensure it transforms industries and creates new jobs in the right way.
“As Australia’s national science agency, a focus on ethics, social licence to operate, and clear national benefit have always determined how we apply science and technology to solve Australia’s greatest challenges,” said Dr Marshall.
“The draft framework contextualises these age-old ethical considerations in the light of new technology, so everyone can have a say in inventing the future we need so our children can keep pace with emerging technologies like AI.”
Adrian Turner, CEO at CSIRO’s Data61, said AI is already here and developing quickly.
“AI represents a powerful general purpose technology that will help Australia solve some of our biggest problems relating to energy, health, ageing, safety, security, climate and the environment.”
“However, we will only realise this potential if we address underlying science and technology challenges in AI itself as well as its implications for people.
"Because of the deep influence AI will have on us all, we need to ensure that these systems work for us and deliver benefits individually and collectively.
"The AI ethics framework identifies principles and tools for achieving this in practice,” said Mr Turner.
New Stories
-
Experienced oncology executive Rosalind Wilson joins Prescient Therapeutics as Chief Medical Officer
June 11, 2026 - -
Hong Kong as the stepping stone into China’s growing healthcare market
June 11, 2026 - - Latest News -
'The changes could cause irreversible damage to our vibrant and world-leading biotech, medtech and health tech sector'
June 11, 2026 - - Latest News -
Cartherics secures Japanese patent to bolster cell therapy push
June 11, 2026 - -
Island secures US partnership to advance Galidesivir dose study for Marburg
June 11, 2026 - - Latest News -
LTR Pharma secures telehealth partnership to launch ROXUS in the United States
June 9, 2026 - - Latest News -
OncoSil Moves to final FDA review stage for humanitarian device exemption
June 9, 2026 - - Latest News